Colombo’s TB Burden: Sri Lanka Sees 9,500 Cases Annually

Sri Lanka’s fight against tuberculosis intensifies, with 8,500-9,500 annual detections underscoring urban vulnerabilities, per National Programme insights. 2025 recorded 8,726 cases—75% pulmonary, 5,500 contagious—straining Colombo’s healthcare grid.

Western Province claims 45% of reports, spotlighting Colombo enclaves like Modara, Mattakuliya, Borella, Wanathamulla, and Grandpass amid population booms. Officials eye a 500-case reduction ahead, fueled by vigilant monitoring.

Primarily lung-afflicting, TB bacteria disperse via aerosols from afflicted exhalations. Latent infection besets 25% globally, inert until activating in 5-10%—graver for youth. Antibiotics cure most, but neglect invites mortality. BCG shields children from ravaging variants.

Enhancing resilience calls for slum upgrades, workplace screenings, and public education on cough etiquette. Sri Lanka leverages WHO partnerships for advanced diagnostics, aiming to halve incidence by decade’s end. This public health battle tests commitment, promising brighter prospects through unified action against an age-old foe.